Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Dec 2019
Historique:
received: 15 11 2019
revised: 04 12 2019
accepted: 06 12 2019
entrez: 29 12 2019
pubmed: 29 12 2019
medline: 7 5 2020
Statut: epublish

Résumé

Immune cells survey and patrol throughout the body and sometimes take residence in niche environments with distinct cellular subtypes and nutrients that may fluctuate from those in which they matured. Rooted in immune cell physiology are metabolic pathways and metabolites that not only deliver substrates and energy for growth and survival, but also instruct effector functions and cell differentiation. Unlike cancer cells, immune cells are not subject to a "Darwinian evolutionary pressure" that would allow them to adapt to developing tumors but are often irrevocably affected to local nutrient deprivation. Thus, immune cells must metabolically adapt to these changing conditions in order to perform their necessary functions. On the other hand, there is now a growing appreciation that metabolic changes occurring in cancer cells can impact on immune cell functionality and contribute to tumor immune evasion, and as such, there is a considerable and growing interest in developing techniques that target metabolism for immunotherapy. In this review, we discuss the metabolic plasticity displayed by innate and adaptive immune cells and highlight how tumor-derived lactate and tumor acidity restrict immunity. To our knowledge, this review outlines the most recent insights on how tumor microenvironment metabolically instructs immune responsiveness.

Identifiants

pubmed: 31881671
pii: ijms21010157
doi: 10.3390/ijms21010157
pmc: PMC6982275
pii:
doi:

Substances chimiques

Amino Acids 0
Lactic Acid 33X04XA5AT
Glucose IY9XDZ35W2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
Antioxid Redox Signal. 2011 Jul 1;15(1):39-47
pubmed: 20673163
Eur J Immunol. 1996 Jun;26(6):1308-13
pubmed: 8647210
Cancer Res. 2003 Mar 15;63(6):1405-12
pubmed: 12649206
Cell. 2011 Sep 2;146(5):772-84
pubmed: 21871655
Cancer Res. 2015 Jan 1;75(1):171-80
pubmed: 25403912
Cell. 2016 Oct 20;167(3):829-842.e13
pubmed: 27745970
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6489-94
pubmed: 16614071
Curr Opin Immunol. 2013 Apr;25(2):214-21
pubmed: 23298609
Cell Metab. 2019 Nov 5;30(5):865-876.e5
pubmed: 31607565
Immunology. 2000 Mar;99(3):375-84
pubmed: 10712667
Nat Immunol. 2015 Nov;16(11):1174-84
pubmed: 26414764
Cell. 2016 Jun 30;166(1):126-39
pubmed: 27368101
Front Immunol. 2017 Apr 03;8:367
pubmed: 28421073
Science. 2003 Feb 14;299(5609):1057-61
pubmed: 12522256
Nat Rev Cancer. 2006 Dec;6(12):924-35
pubmed: 17109012
J Immunother Cancer. 2016 Feb 16;4:4
pubmed: 26885366
Immunity. 2017 Jun 20;46(6):1089-1090
pubmed: 28636957
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
J Nutr Biochem. 1999 Jun;10(6):316-24
pubmed: 15539305
Exp Mol Med. 2013 Oct 04;45:e45
pubmed: 24091747
Front Immunol. 2015 Sep 14;6:471
pubmed: 26441976
J Immunol. 2003 Aug 1;171(3):1232-9
pubmed: 12874210
Immunity. 2005 May;22(5):633-42
pubmed: 15894280
Blood. 2006 Mar 1;107(5):2013-21
pubmed: 16278308
Biochemistry. 2000 Oct 24;39(42):13005-11
pubmed: 11041866
Cell Rep. 2015 Oct 27;13(4):760-770
pubmed: 26489460
Nat Commun. 2018 Nov 30;9(1):5099
pubmed: 30504842
Expert Opin Biol Ther. 2014 Jul;14(7):931-45
pubmed: 24661020
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1491-6
pubmed: 11792859
Nat Immunol. 2018 Dec;19(12):1319-1329
pubmed: 30397348
J Biol Chem. 2004 Aug 6;279(32):33352-8
pubmed: 15184389
Oncoimmunology. 2013 Jul 1;2(7):e25443
pubmed: 24073382
Nat Med. 2016 Feb;22(2):146-53
pubmed: 26779811
Nat Commun. 2017 Apr 21;8:15074
pubmed: 28429737
Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4547-52
pubmed: 17360561
Cell Death Differ. 2004 Feb;11(2):143-53
pubmed: 14576767
Nature. 2014 Sep 25;513(7519):559-63
pubmed: 25043024
FASEB J. 2012 Jan;26(1):376-86
pubmed: 21926236
J Immunol. 2009 Feb 15;182(4):2476-84
pubmed: 19201903
Cell Metab. 2008 Jan;7(1):11-20
pubmed: 18177721
J Cell Physiol. 1985 Aug;124(2):275-82
pubmed: 4044655
Nat Immunol. 2013 May;14(5):500-8
pubmed: 23525088
Cancers (Basel). 2016 Nov 24;8(12):
pubmed: 27886124
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
pubmed: 18032601
Cancer Lett. 2015 Aug 1;364(1):1-7
pubmed: 25917076
J Immunol. 2004 Mar 1;172(5):3196-204
pubmed: 14978127
Nat Chem Biol. 2009 Oct;5(10):721-3
pubmed: 19718041
J Immunol. 2010 Feb 1;184(3):1200-9
pubmed: 20026743
J Biol Chem. 2018 Oct 12;293(41):15947-15961
pubmed: 30158244
iScience. 2018 Jul 27;5:99-109
pubmed: 30240649
Cancer Res. 2014 Jul 15;74(14):3652-8
pubmed: 24986517
Blood. 1997 Aug 15;90(4):1600-10
pubmed: 9269779
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9533-9542
pubmed: 31019077
Nat Immunol. 2014 Aug;15(8):749-757
pubmed: 24973821
J Clin Invest. 2002 Oct;110(7):993-1002
pubmed: 12370277
EMBO J. 2003 Aug 15;22(16):4082-90
pubmed: 12912907
J Immunother. 2000 Mar-Apr;23(2):196-207
pubmed: 10746546
Cell. 2014 Jan 16;156(1-2):317-331
pubmed: 24439385
Cell Metab. 2016 Nov 8;24(5):657-671
pubmed: 27641098
Immunity. 2013 Feb 21;38(2):225-36
pubmed: 23415911
Nat Immunol. 2010 Apr;11(4):344-9
pubmed: 20208539
Trends Immunol. 2012 Apr;33(4):168-73
pubmed: 22342741
Oncol Rep. 2013 Feb;29(2):685-9
pubmed: 23229496
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14711-6
pubmed: 23964122
Annu Rev Physiol. 2017 Feb 10;79:541-566
pubmed: 27813830
Front Immunol. 2016 Feb 16;7:52
pubmed: 26909082
Oncotarget. 2016 May 24;7(21):30193-210
pubmed: 27070086
Cancer Discov. 2012 Jul;2(7):608-23
pubmed: 22719018
Cell Metab. 2017 Feb 7;25(2):345-357
pubmed: 28111214
Nat Immunol. 2016 Dec;17(12):1459-1466
pubmed: 27695003
PLoS One. 2017 Feb 2;12(2):e0171215
pubmed: 28152020
Cancer Cell. 2013 Dec 9;24(6):695-709
pubmed: 24332039
J Clin Invest. 2013 Sep;123(9):3652-8
pubmed: 23999438
Pflugers Arch. 2004 Feb;447(5):469-79
pubmed: 14530974
Cancer Cell. 2016 Sep 12;30(3):391-403
pubmed: 27622332
Cancer Res. 2019 Feb 1;79(3):611-624
pubmed: 30545920
Mol Cancer Res. 2006 Feb;4(2):61-70
pubmed: 16513837
Nat Rev Cancer. 2013 Sep;13(9):611-23
pubmed: 23969692
Cancer Res. 2016 Mar 15;76(6):1381-90
pubmed: 26719539
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Lancet Oncol. 2019 Aug;20(8):1083-1097
pubmed: 31221619
Clin Cancer Res. 2017 Jul 1;23(13):3241-3250
pubmed: 28341752
Cell. 2015 Sep 10;162(6):1217-28
pubmed: 26321681
J Immunol. 2008 Dec 15;181(12):8382-90
pubmed: 19050255
Nat Immunol. 2017 Mar;18(3):303-312
pubmed: 28114292
Oncogene. 2008 Jun 26;27(28):3889-900
pubmed: 18317452
Histol Histopathol. 2011 Jul;26(7):941-51
pubmed: 21630223
J Biol Chem. 1994 Dec 16;269(50):31484-90
pubmed: 7989314
Elife. 2017 Aug 15;6:
pubmed: 28826492
JCI Insight. 2017 Jun 15;2(12):null
pubmed: 28614802
Nat Rev Cancer. 2017 Dec;17(12):709-724
pubmed: 29059149
ACS Nano. 2016 Sep 27;10(9):8956-63
pubmed: 27599066
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20262-7
pubmed: 18077379
Cancer Res. 2006 Jan 15;66(2):605-12
pubmed: 16423985
Oncotarget. 2015 Sep 8;6(26):21853-64
pubmed: 26392411
Cell Metab. 2006 Mar;3(3):187-97
pubmed: 16517406
J Leukoc Biol. 2015 Feb;97(2):273-8
pubmed: 25492936
Cell Metab. 2015 Sep 1;22(3):508-15
pubmed: 26190651
J Cell Biochem. 2019 Mar;120(3):2756-2765
pubmed: 30270458
Nat Rev Clin Oncol. 2019 Jun;16(6):372-385
pubmed: 30837712
Cancers (Basel). 2011 Jul 22;3(3):3002-17
pubmed: 24310356
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18782-7
pubmed: 19033189
J Immunol Methods. 2016 Nov;438:51-58
pubmed: 27594594
Nature. 2001 Dec 20-27;414(6866):916-20
pubmed: 11780065
J Immunol. 2006 Oct 15;177(8):4962-5
pubmed: 17015677
Immunity. 2002 Jun;16(6):769-77
pubmed: 12121659
J Biol Chem. 1996 Dec 20;271(51):32529-37
pubmed: 8955077
Cancer Res. 2012 Jun 1;72(11):2746-56
pubmed: 22593198
Cell Rep. 2019 Oct 1;29(1):135-150.e9
pubmed: 31577944
J Immunol. 2011 Mar 15;186(6):3299-303
pubmed: 21317389
Int J Tryptophan Res. 2009;2:1-19
pubmed: 22084578
Immunity. 2014 May 15;40(5):692-705
pubmed: 24792914
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
Trends Immunol. 2015 Apr;36(4):257-64
pubmed: 25773310
IUBMB Life. 2012 Jan;64(1):1-9
pubmed: 22131303
Cancer Res. 1964 Nov;24:1727-32
pubmed: 14230919
Am J Pathol. 2003 Oct;163(4):1233-43
pubmed: 14507633
Cancer Res. 1997 Jul 1;57(13):2602-5
pubmed: 9205063
J Immunol. 2003 Feb 15;170(4):1964-72
pubmed: 12574365
Surg Oncol. 2006 Dec;15(4):217-22
pubmed: 17320378
Cancer Discov. 2016 Jun;6(6):630-49
pubmed: 27072748
Cell. 2012 Jun 8;149(6):1269-83
pubmed: 22682249
Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14336-41
pubmed: 23940348
J Cell Physiol. 2008 Jun;215(3):593-602
pubmed: 18181196
Oncotarget. 2018 Jun 1;9(42):26868-26883
pubmed: 29928490
Blood. 2009 Jan 1;113(1):224-32
pubmed: 18812468
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1632-7
pubmed: 15665078
J Exp Med. 1999 May 3;189(9):1363-72
pubmed: 10224276
Q J Exp Physiol. 1985 Oct;70(4):473-89
pubmed: 3909197
Immunity. 2015 Jan 20;42(1):41-54
pubmed: 25607458
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17071-6
pubmed: 16286658
Proc Natl Acad Sci U S A. 1990 May;87(9):3343-7
pubmed: 1970635
Int J Exp Pathol. 2009 Jun;90(3):222-31
pubmed: 19563607
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Oncotarget. 2015 Apr 10;6(10):7944-58
pubmed: 25760243
Nat Rev Cancer. 2012 Mar 22;12(4):278-87
pubmed: 22437872
J Immunol. 2019 Nov 15;203(10):2571-2576
pubmed: 31597706
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Nat Rev Cancer. 2012 Mar 22;12(4):252-64
pubmed: 22437870
Immunol Rev. 2010 Jul;236:190-202
pubmed: 20636818
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17073-8
pubmed: 18952840
Mol Cell Biochem. 2007 Jul;301(1-2):1-12
pubmed: 17180248
J Cell Mol Med. 2010 Apr;14(4):771-94
pubmed: 20015196
Front Oncol. 2018 Mar 28;8:86
pubmed: 29644214
Immunol Rev. 2012 Sep;249(1):27-42
pubmed: 22889213
Crit Rev Biochem Mol Biol. 2000;35(2):71-103
pubmed: 10821478
Trends Pharmacol Sci. 2016 Dec;37(12):1009-1028
pubmed: 27745709
Cancer Cell. 2008 Jun;13(6):472-82
pubmed: 18538731
Sci Signal. 2015 Sep 29;8(396):ra97
pubmed: 26420908
Cell Metab. 2016 Nov 8;24(5):701-715
pubmed: 27773694
Nat Immunol. 2017 Nov;18(11):1197-1206
pubmed: 28920951
Cell Metab. 2006 Mar;3(3):177-85
pubmed: 16517405
Free Radic Biol Med. 2016 Nov;100:175-181
pubmed: 27117029
Nature. 2019 Oct;574(7779):575-580
pubmed: 31645732
J Immunol. 2006 Nov 15;177(10):6695-704
pubmed: 17082582
Immunity. 2018 Feb 20;48(2):202-213
pubmed: 29466753
Oncol Rep. 2009 Jun;21(6):1449-54
pubmed: 19424622
Curr Opin Immunol. 2011 Apr;23(2):286-92
pubmed: 21185705
J Immunol. 2013 Sep 15;191(6):3090-9
pubmed: 23956421
Science. 2009 Jun 5;324(5932):1334-8
pubmed: 19498172
J Neuroimmunol. 2007 Apr;185(1-2):9-19
pubmed: 17303252
Cancer Res. 2004 Aug 15;64(16):5839-49
pubmed: 15313928
Cell Cycle. 2018;17(7):903-916
pubmed: 29633904
Eur J Immunol. 2001 Sep;31(9):2829-38
pubmed: 11536182
Cell. 1980 Apr;19(4):821-7
pubmed: 6991122
Curr Opin Chem Biol. 2019 Feb;48:96-105
pubmed: 30508703
Front Immunol. 2014 Oct 17;5:514
pubmed: 25368618
Int J Cancer. 2005 Dec 10;117(5):701-8
pubmed: 16106399
Cell Rep. 2019 Sep 17;28(12):3011-3021.e4
pubmed: 31533027
J Immunol. 2010 Jul 15;185(2):1037-44
pubmed: 20554958
Semin Cancer Biol. 2017 Apr;43:74-89
pubmed: 28267587
J Immunol. 2013 Aug 1;191(3):1486-95
pubmed: 23817426
Front Immunol. 2015 Feb 03;6:34
pubmed: 25691885
J Hematol Oncol. 2017 Feb 28;10(1):58
pubmed: 28241846
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
Cancer Res. 2019 Aug 1;79(15):3877-3890
pubmed: 31175120
Eur J Immunol. 2008 Sep;38(9):2438-50
pubmed: 18792400
Biochim Biophys Acta. 2016 Oct;1863(10):2465-80
pubmed: 26944480
Immunity. 2011 Dec 23;35(6):871-82
pubmed: 22195744
Sci Rep. 2012;2:266
pubmed: 22355778
Cancer Res. 2015 Feb 1;75(3):544-53
pubmed: 25644265
Nat Med. 2003 Oct;9(10):1269-74
pubmed: 14502282
J Immunol. 2014 Nov 1;193(9):4477-84
pubmed: 25261477
Cancer Res. 2005 Oct 1;65(19):8896-904
pubmed: 16204061
Blood. 2006 Jun 1;107(11):4458-65
pubmed: 16449529

Auteurs

Shamir Cassim (S)

Department of Medical Biology, Centre Scientifique de Monaco, CSM, 98000 Monaco, Monaco.

Jacques Pouyssegur (J)

Department of Medical Biology, Centre Scientifique de Monaco, CSM, 98000 Monaco, Monaco.
University Côte d'Azur, IRCAN, CNRS, Centre A. Lacassagne, 06189 Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH